Cardiovascular Clinical Consult

A key opinion leader discusses the most significant unmet needs in the evolving spectrum of cardiovascular risk management.

A discussion on recent data updates from the REDUCE-IT trial, and their practical implications for physicians managing cardiovascular risk.

An expert physician discusses the role of agents that reduce triglyceride levels and the potential on cardiovascular risk.

A discussion on which factors to consider when assessing the need for management/reduction of cardiovascular risk.

A key opinion leader discusses effective risk prevention measures and challenges to reducing adverse events. He also considers effective educational resources for self-care.

This article reviews the evolving therapeutic landscape for lowering LDL-C and cardiovascular risk, with an emphasis on the role of omega-3 fatty acids.